Tellimer

ID : Summarecon Agung - Maintaining neutral view on rights issue

SMRA announced a Rp720/share exercise price for its upcoming rights issue, in which it will issue a max of 2.1bn new shares with proceeds of Rp1.5tr. The impact from the rights issue is overall rather neutral to our FY21-22F estimates, i.e. core EPS accretion of 4-7%, RNAV/share dilution of 2-10%. If fully subscribed, the rights issue would have limited downside risk to TP, in our view. Potential new township development may pose upside risk to TP.


Most Viewed See latest
Disclosures

This publication is being distributed by Tellimer solely for information purposes irrespective of a particular user's means, financial situation or investment objectives. The information does not con...

Full Tellimer disclaimers